Ohio Medical Solutions will manufacture and wholesale Vireo-branded medical cannabis products to third-party dispensaries throughout the Buckeye State
MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO,OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company’s affiliate, Ohio Medical Solutions (“OMS”), was granted a Certificate of Operation by the Ohio Department of Commerce. OMS, which will begin operating immediately, was previously awarded a provisional processing license.
OMS is now permitted to purchase plant material from licensed cultivators, manufacture a wide variety of Vireo-branded pharmaceutical-grade cannabis products, and wholesale these products to third-party dispensaries throughout the state of Ohio.
We are delighted that Ohio Medical Solutions will begin manufacturing Vireo products for the benefit of Ohio patients. The City of Akron has been great to us and as our business grows, we look forward to continuing to create new jobs and make a positive impact on the local economy.
Kyle Kingsley, M.D., Chief Executive Officer at Vireo
Located in a former factory building that had fallen into disuse and disrepair, the Company’s 11,500 square-foot facility, in Akron, Ohio has been transformed, through a multi-million-dollar investment, into a state-of-the-art pharmaceutical manufacturing facility. The renovated facility features new building systems, a new roof, complete interior redesign, and the installation of a best-in-class security system and fence.
“I am honored to serve as General Manager and lead this facility,” said Marie Walchalk, OMS General Manager. “As a life-long Ohioan I have personally witnessed too many manufacturing jobs leave our State and it’s great to be part of an industry adding new good-paying local jobs.”
Ohio’s Medical Marijuana Bill (HB 523) was signed into law on June 8, 2016 by Governor Kasich. The State’s medical marijuana program is rapidly expanding. Sales of medical marijuana officially began on January 16, 2019. There are now 527 certified physicians and 25 active dispensaries serving the State’s 53,082 registered patients and almost 4,000 registered caregivers.
About Vireo Health International, Inc.
Vireo Health International, Inc.’s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo’s physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, New Mexico, New York, Nevada, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the company, please visit www.vireohealth.com.
Vice President, Investor Relations
Vice President, Corporate Communications
This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.